Skip to content

External Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac Surgery

External Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05640518
Acronym
ValiVexus
Enrollment
119
Registered
2022-12-07
Start date
2022-12-19
Completion date
2024-11-30
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure, Acute Renal Insufficiency, Renal Failure, Renal Insufficiency

Keywords

Renal failure, Cardiac surgery, VExUS score, venous congestion

Brief summary

Acute renal failure is a frequent complication associated with significant morbidity and mortality in postoperative cardiac surgery. The VExUS (Venous Excess UltraSound grading system) score was created to qualitatively assess this venous congestion, based on ultrasound data from patients obtained post operatively in cardiac surgery. These data included: inferior vena cava diameter, Doppler flow of the suprahepatic veins, portal trunk and renal veins. This score is predictive of the onset of acute renal failure in the first 3 days after surgery. The VExUS score has not been validated in an external and prospective way in cardiac surgery.

Detailed description

Acute renal failure is a frequent complication associated with significant morbidity and mortality in postoperative cardiac surgery. The pathophysiology in this context is complex, poorly understood and the causes are multiple: underlying nephropathy, intra- or postoperative haemodynamic instability, the use of an extracorporeal circulation, inflammation, etc. One of the other possible etiologies is venous congestion. This may be due to volume overload and/or isolated global or right heart dysfunction. Early treatment could prevent the onset of ARF or reduce its consequences, hence the importance of being able to predict its onset. The VExUS (Venous Excess UltraSound grading system) score was created to qualitatively assess this venous congestion, based on ultrasound data from patients obtained post operatively in cardiac surgery. These data included: inferior vena cava diameter, Doppler flow of the suprahepatic veins, portal trunk and renal veins. This score is predictive of the onset of acute renal failure in the first 3 days after surgery. The VExUS score has not been validated in an external and prospective way in cardiac surgery.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled cardiac surgery * Affiliated to a social security system

Exclusion criteria

* Emergency surgery * Chronic renal failure defined by a glomerular filtration rate of less than 30ml/min or dialysis. * renal transplant recipients * Cirrhosis and portal hypertension * Setting up a left ventricular assist device implantation * Patient under ECMO (ExtraCorporeal Membrane Oxygenation), intra-aortic balloon pump, or a mechanical circulatory support device such as IMPELLA * No available operator to perform ultrasound scans * Patients objecting to the use of their data in research * Subject under guardianship or subject deprived of freedom * Pregnant or breastfeeding women * Resume surgery within 48 hours of scheduled surgery * Lack of a trained operator to perform D+1 and D+2 ultrasound

Design outcomes

Primary

MeasureTime frameDescription
Association between the change in ultrasound data collected in the VExUS score and postoperative acute renal failure (defined by a creatininemia increase by 26.5 µmol/L in 48 hours).From date of randomization until date of post-operative acute renal failure (detected by daily creatininemia), assessed up to a variable period of time estimated to 2 weeks.correlation between operator in term of VExUS staging (VExUS score will be assessed at day 1, 2 and 3 after the surgery, in intensive care unit.
Association between the change in ultrasound data collected in the VExUS score and postoperative acute renal failure.From date of randomization until date of post-operative acute renal failure (detected by daily creatininemia), assessed up to a variable period of time estimated to 2 weeksSpecificity of the VExUS score to predict an acute kidney failure will be evaluated

Secondary

MeasureTime frameDescription
Correlation between central venous pressure (CVP) and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value3 daysCentral venous pressure (CVP). The values will be taken during the ultrasound scans at Day 0, Day 1 and Day 2. The units of pressure are mmHg. A value greater than 12mmHg will be considered high, a lower value as not high. The CVP is measured by a central venous line.
Correlation between daily fluid balance and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value3 daysWater balance: 24-hour input-output balance, in millilitres, collected daily. Values measured at Day 0, Day 1, Day 2
Correlation between an isolated component of the VExUS score, echocardiography and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value3 daysAn isolated component of the VExUS score that is measured at D0; D1; D2 by ultrasound 1. Inferior vena cava diameter 2. Doppler profile of the suprahepatic vein 3. Doppler profile of portal vein 4. Renal vein Doppler profile
Correlation between an echocardiographic abnormality and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value.3 daysUltrasound assessment of the left and right heart: Visual LVEF, sub-aortic LTI, Mitral Doppler (E wave, A wave, E/A ratio, deceleration time), LV/VD ratio (less than or greater than 0.6); TAPSE (unit: mm); S wave (unit: cm/seconds); LTI flow (unit: m/seconds); diameter (unit: mm) and ICV compliance. Values also taken at D0, D1 and D2.
Correlation between the VExUS score and a postoperative acute renal failure3 daysUse of a multivariable COX regression to evaluate the correlation between the VExUS score measured at day 1, 2 and 3 and a post-operative acute renal failure during the stay in intensive care unit
Correlation between VExUS score and length of stayFrom randomization until date of discharge, assessed up to a variable period of time estimated to 2 weeks.Length of stay in days: in intensive care, cardiac surgery and rehabilitation. Determined thanks to medical records.
Correlation between VExUS score and 1-month mortality1 month after admission in intensive careMortality: binary (yes/no) at 1 month. The data will be collected by phone call to the patient or a relative, or by consulting the medical record.
Correlation between renal arterial resistance index and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV)3 daysRenal arterial resistance index are measured at D0; D1; D2 during the ultrasound scans.
Correlation between renal venous impedance index and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV)3 daysVeinous impedance index are measured at D0; D1; D2 during the ultrasound scans.
Correlation between VExUS score and the use of extra renal replacement therapyFrom randomization until date of postoperative need of extra renal replacement therapy, assessed up to a variable period of time estimated to 2 weeks.Use of extra renal replacement therapy: based on dialysis prescriptions, binary value (yes/no) regardless of the method used (CVVHF, CVVHDF, CVVHD)
Diagnostic performances of the VExUS Score for postoperative acute renal failure3 daysSensitivity, NPV, PPV

Countries

France

Contacts

Primary ContactTimothée ABAZIOU, MD
tabaziou@chu-grenoble.fr04 76 76 68 79
Backup ContactMehdi KARAOUI
MKaraoui@chu-grenoble.fr04 76 76 68 79

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026